Health Care & Life Sciences » Pharmaceuticals | Lanzhou Foci Pharmaceutical Co. Ltd.

Lanzhou Foci Pharmaceutical Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
30,596.40
34,652.90
42,947.60
60,926.20
74,092.80
74,278.60
Depreciation, Depletion & Amortization
15,338.00
15,050.00
18,122.00
18,527.30
21,058.00
34,235.30
Other Funds
19,788.50
3,581.20
842.50
15,090.50
2,283.20
2,844.40
Funds from Operations
54,237.60
51,835.60
57,868.40
79,722.60
98,421.40
111,788.90
Changes in Working Capital
64,712.10
41,911.10
6,246.00
22,821.60
31,998.30
60,917.10
Net Operating Cash Flow
10,474.40
93,746.70
64,114.40
56,901.00
66,423.10
50,871.80
Capital Expenditures
85,813.00
48,358.50
51,918.00
266,999.70
442,770.90
Sale of Fixed Assets & Businesses
99.10
172,811.50
4,544.90
496,302.00
-
Net Investing Cash Flow
85,713.90
124,453.10
47,373.00
229,302.40
442,770.90
Cash Dividends Paid - Total
-
2,807.30
3,304.40
4,595.90
6,127.80
Issuance/Reduction of Debt, Net
48,000.00
98,000.00
26,000.00
107,000.00
-
Net Financing Cash Flow
67,788.50
104,388.50
428,043.10
87,313.60
3,844.70
Net Change in Cash
28,156.60
113,804.70
445,326.40
373,556.30
380,192.50
Free Cash Flow
96,287.40
45,388.20
12,196.50
210,098.60
376,347.80
Deferred Taxes & Investment Tax Credit
513.00
416.50
1,225.90
713.50
511.10
430.60
Change in Capital Stock
-
-
458,190.00
-
-
Exchange Rate Effect
243.30
6.50
541.90
39.30
-

About Lanzhou Foci Pharmaceutical Co.

View Profile
Address
No. 68 Foci Avenue
Lanzhou Gansu 730046
China
Employees -
Website http://www.fczy.com
Updated 07/08/2019
Lanzhou Foci Pharmaceutical Co., Ltd. engages in the manufacture and sale of traditional Chinese medicine. The form of product includes pills, tablets, granules, hard capsules, concentrated decoctions, mixture, oral liquid, syrup, and medicinal wine. The pills consist of concentrated, concentrated water, concentrated honey, water, small honey, big honey, and concentrated water honey pills.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.